#SLRN

Justice Technology Association

@justicetechassn.bsky.social

3 months ago

The 2026 Access to Justice Network Conference is now open for session proposals! If you’re building, researching, organizing, or imagining new ways to expand access to justice, this is your space.

📅 Oct 20–22, 2026 - Cincinnati

📝 Proposal form: buff.ly/qFx1OGl

⏳ Due Jan 7

#Access2Justice #SLRN

exCelsior

@celsiorucf30.bsky.social

8 months ago

#teamchastity #teamlocked #owned #slrn #slavereg #cagecheck #lockedsub #collared #caged #gaychastity

Anu Bansal

@stockholderrights.bsky.social

10 months ago

In an Apr 28 letter, Trium urges liquidation, citing higher shareholder value and lower risk. Acelyrin #SLRN rejected a $3/share buyout from Tang Capital, pushing for the merger, set to close Q2 2025.

StockTitan

@stocktitan.net

10 months ago

Alumis and ACELYRIN Announce Amended Merger Agreement ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger maximizes the potential value for ACELYRIN

#SLRN Alumis and ACELYRIN Announce Amended Merger Agreement

www.stocktitan.net/news/SLRN/alumis-and-ace...

StockTitan

@stocktitan.net

1 year ago

ACELYRIN's Defensive Move: New Rights Plan Blocks Hostile Takeover After Major Stake Purchase ACELYRIN implements stockholder rights plan following Tang Capital's 8.8% stake acquisition. Plan triggers at 10% ownership, protecting shareholders from hostile takeover attempts.

#SLRN ACELYRIN Adopts Limited-Duration Stockholder Rights Plan

www.stocktitan.net/news/SLRN/acelyrin-adopt...

Small Cap Strategist

@smcapstrategist.bsky.social

1 year ago

Small-cap stocks with improving money flow, Tue Mar 11th - #UFCS #ZVRA #RGR #TSVT #SLRN #RANI #QURE #PFC #MMLP #INBX #CRVO #BLTE - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

1 year ago

Can ACELYRIN's $737M War Chest Transform Immune Disease Treatment Following Alumis Merger? Combined entity boasts strong cash position and diversified late-stage portfolio targeting multi-billion dollar markets in immune-mediated diseases.

#SLRN ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

www.stocktitan.net/news/SLRN/acelyrin-and-a...

StockTitan

@stocktitan.net

1 year ago

Why ACELYRIN Turned Down Concentra's Offer to Stick With Alumis Merger ACELYRIN's Board determined Tang Capital's Concentra proposal wouldn't deliver superior value compared to the planned Alumis merger set to close in Q2 2025.

#SLRN ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger

www.stocktitan.net/news/SLRN/acelyrin-deter...

StockTitan

@stocktitan.net

1 year ago

Can This New Cash Offer Derail ACELYRIN's Planned Alumis Merger? Concentra proposes $3.00 cash per share plus 80% CVR rights, challenging ACELYRIN's existing merger agreement with Alumis. Board evaluating competing strategic options.

#SLRN ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences

www.stocktitan.net/news/SLRN/acelyrin-confi...

StockTitan

@stocktitan.net

1 year ago

ACELYRIN's Thyroid Eye Disease Drug Shows Promise in Phase 2, Advances to Pivotal Trials ACELYRIN's lonigutamab demonstrates significant improvements in TED symptoms. Phase 3 LONGITUDE program set for 2025 with FDA-aligned design spanning 350 patients.

#SLRN ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease

www.stocktitan.net/news/SLRN/acelyrin-inc-a...

StockTitan

@stocktitan.net

1 year ago

ACELYRIN's Izokibep Trial Fails Primary Endpoint in Uveitis Study, Shifts Focus to Thyroid Eye Disease Program ACELYRIN discontinues izokibep program after missing primary endpoint in uveitis trial. Company pivots to promising thyroid eye disease candidate with $562M cash runway.

#SLRN ACELYRIN, INC. Announces Topline Results From Phase 2b/3 Study of Izokibep for the Treatment of Uveitis

#news #investing #stocks

www.stocktitan.net/news/SLRN/acelyrin-inc-a...

InsiderFinance

@insiderfinance.com

1 year ago

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #AISP 254.0x
2. #POOL 240.4x
3. #ARKX 64.0x
4. #SLRN 38.6x
5. #PAY 24.0x

#OptionFlow #OptionsTrading #Trading

StockTitan

@stocktitan.net

1 year ago

#SLRN ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights

www.stocktitan.net/news/SLRN/acelyrin-inc-r...

👣@bft4evr👣 22-633-516-437

@bft4evr.bsky.social

2 years ago

Looking forward to the training tomorrow with @gayslaveacademy!
#gayBDSM #chastity #PAlocked #KTB #BallWeight #barefoot #shackles #barefoot #malefeet #ballandchain #SLRN #bondage #toecuffs